lae-32 lae-32 d-lysergic acid ethylamide (lae-32) is a derivative of ergine. it is reported to have some lsd-like effects but is weaker and shorter lasting, with an active dose reported to be between 0.5 and 1.5 milligrams. lae-32clinical dataother nameslae; lysergic acid ethylamide; d-lysergic acid ethylamide; d-ethyllysergamide,routes ofadministrationoralpharmacokinetic datametabolismhepaticexcretionrenalidentifiers iupac name (8β)-n-ethyl-6-methyl-9,10-didehydroergoline-8-carboxamide cas number478-99-9 ypubchem cid101704chemspider19975296 yunii72370wpf0jcomptox dashboard (epa)dtxsid20963946 chemical and physical dataformulac18h21n3omolar mass295.386 g·mol−13d model (jsmol)interactive image smiles ccnc(=o)2c=c1c3cccc4cc(c1n(c)c2)c34 inchi inchi=1s/c18h21n3o/c1-3-19-18(22)12-7-14-13-5-4-6-15-17(13)11(9-20-15)8-16(14)21(2)10-12/h4-7,9,12,16,20h,3,8,10h2,1-2h3,(h,19,22)/t12-,16-/m1/s1 ykey:vebwtgyuibtvnr-mlgollrusa-n y (verify) it was studied by the cia as part of project mkultra. documents published by the cia under the freedom of information act suggest it causes "a schizophrenia-like condition" but it allows people with schizophrenia to remain indifferent to their disorder.